Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements

Purpose: To demonstrate the accuracy and sensitivity of Representational Oligonucleotide Microarray Analysis (ROMA) to describe copy number changes in patients with chromosomal abnormalities.Methods: ROMA was performed using BglII digested DNA from two cases with cytogenetically detected deletions and one case with an unbalanced terminal rearrangement detected only by subtelomeric FISH. Hybridization was to an 85,000-probe oligonucleotide microarray, providing an average resolution of 35 kb. FISH was used to confirm some of the ROMA findings.Results: By ROMA, a del(13)(q14.3q21.2) was shown to be noncontiguous, with deletions extending from 53.08 to 61.40 Mb and from 72.88 to 74.83 Mb. The 10-Mb deletion contained only six known genes. FISH confirmed the noncontiguous nature of the deletion, as well as a small amplification in 6q that was also found in the patient's mother. A del(4)(q12q21.2) was found by ROMA to be 23 Mb in length, from 58.8 to 81.9 Mb on chromosome 4, in agreement with the cytogenetically assigned breakpoints. ROMA showed that an unbalanced “subtelomeric” rearrangement involved a 6-Mb deletion of 22q and an 8-Mb duplication of 16q.Conclusions: ROMA can define cytogenetic aberrations with extraordinary precision. Unexpected findings included the interrupted nature of the deletion in 13q and the large size of the imbalances in the “subtelomeric” rearrangement. Together with the information from the human genome sequence and proteomics, the ability to define rearrangements with “ultra-high” resolution will improve the ability to provide accurate prognosis both prenatally and postnatally to parents of offspring with chromosomal aberrations.

[1]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[2]  M Bobrow,et al.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features , 2004, Journal of Medical Genetics.

[3]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[4]  Patrick G Buckley,et al.  Genomic microarrays in the spotlight. , 2004, Trends in genetics : TIG.

[5]  I. Dunham,et al.  DNA sequence and analysis of human chromosome 9 , 2003, Nature.

[6]  J. Nielsen,et al.  Deletion long arm 13 , 1977, Human Genetics.

[7]  B. Dutrillaux,et al.  Deletion of band 13q21 is compatible with normal phenotype , 2004, Human Genetics.

[8]  I. Dunham,et al.  The DNA sequence and analysis of human chromosome 13 , 2004, Nature.

[9]  J. Sebat,et al.  Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. , 2003, Genome research.

[10]  J. Schwartz,et al.  Annotating large genomes with exact word matches. , 2003, Genome research.

[11]  Chad A Shaw,et al.  Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions. , 2003, Human molecular genetics.

[12]  G. Seki,et al.  Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. , 2002, Journal of the American Society of Nephrology : JASN.

[13]  A. Lang,et al.  The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.

[14]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[15]  Y. Agid,et al.  A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. , 1999, Human molecular genetics.

[16]  K. Anyane-Yeboa,et al.  Preliminary definition of a "critical region" of chromosome 13 in q32: report of 14 cases with 13q deletions and review of the literature. , 1993, American journal of medical genetics.

[17]  J. Dean,et al.  Interstitial deletion of chromosome 13: prognosis and adult phenotype. , 1991, Journal of medical genetics.

[18]  R. Neu,et al.  A case of 48,XXY,21+ in an infant with Down's syndrome. , 1971, Journal of medical genetics.